Infectious Diseases: Hepatitis B and C: Ascletis has developed a comprehensive portfolio of therapies targeting hepatitis B and C

Infectious Diseases: Hepatitis B and C: Ascletis has developed a comprehensive portfolio of therapies targeting hepatitis B and C, aiming to cure these chronic viral infections.HIV: The company is also engaged in the development of innovative treatments for HIV, focusing on improving the quality of life for patients.Oncology: Liver Cancer: Ascletis is actively developing novel therapies for liver cancer, utilizing its expertise in viral hepatitis to address related oncological challenges.Other Cancers: The company’s oncology pipeline includes treatments for various cancers, emphasizing targeted therapies and immunooncology.